The emerging role of COX-2, 15-LOX and PPARγ in metabolic diseases and cancer: an introduction to novel multi-target directed ligands (MTDLs)

RA Alaaeddine, PA Elzahhar, I AlZaim… - Current Medicinal …, 2021 - ingentaconnect.com
Emerging evidence supports an intertwining framework for the involvement of different
inflammatory pathways in a common pathological background for a number of disorders. Of …

[HTML][HTML] Analysis of MMP-2-735C/T (rs2285053) and MMP-9-1562C/T (rs3918242) Polymorphisms in the Risk Assessment of Developing Lung Cancer

K Wadowska, P Błasiak, A Rzechonek… - International Journal of …, 2023 - mdpi.com
Matrix metalloproteinase (MMP)-2 and-9 are gelatinases which are capable of degrading
type IV collagen and have been linked to cancer invasion and metastatic development. MMP …

Polymorphisms of COX/PEG2 pathway-related genes are associated with the risk of lung cancer: a case–control study in China

X Liang, J Wang, Y Liu, L Wei, F Tian, J Sun… - International …, 2022 - Elsevier
Abstract Background The COX/PGE2 pathway is widely involved in the development of
tumors and the regulation of tumor immune cells such as T cells, NK cells and DCs …

Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region

SB Anyona, NW Hengartner, E Raballah… - Journal of human …, 2020 - nature.com
Abstract Cyclooxygenase-2 [(COX-2) or prostaglandin endoperoxide H2 synthase-2 (PTGS-
2)] induces the production of prostaglandins as part of the host-immune response to …

Associations between folate metabolism enzyme polymorphisms and lung cancer: a meta-analysis

F Chen, T Wen, Q Lv, F Liu - Nutrition and cancer, 2020 - Taylor & Francis
Some previous studies already investigated potential associations between folate
metabolism enzyme polymorphisms and lung cancer (LC). However, the results of these …

[HTML][HTML] Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients

LM González, NR Robles, S Mota-Zamorano… - Scientific Reports, 2023 - nature.com
Nephrosclerosis patients are at an exceptionally high cardiovascular (CV) risk. We aimed to
determine whether genetic variability represented by 38 tag-SNPs in genes of the …

Certain interleukin polymorphisms might influence predisposition to lung cancer: A meta‐analysis of 35 published studies

J Gao, Y Ying, J Wang, Y Cui, W Zhang - IUBMB life, 2020 - Wiley Online Library
Interleukin polymorphisms might influence predisposition to lung cancer (LC), but the results
of already published studies regarding the relationship between interleukin polymorphisms …

[PDF][PDF] COX-2 rs689466 polymorphism correlates with increased lung cancer risk

J Wang, GM Li, XD Wang, FY Zhao, Y Li, JG Sun… - Int J Clin Exp …, 2019 - e-century.us
Background: The aim of this study was to assess, using comprehensive meta-analysis, if
there was a significant association between polymorphisms in cyclooxygenase-2 (COX-2) …

[HTML][HTML] Prostaglandin Synthase 2/Cyclooxygenase 2 Gene Polymorphisms and Susceptibility to Urothelial Bladder Cancer in an Iranian Population

K Mansori, MR Nowroozi, A Farzin… - Middle East Journal …, 2022 - journals.sums.ac.ir
Background: Prostaglandin-endoperoxide synthase 2, recognized as cyclooxygenase 2
(COX-2), is an important enzyme contributing to the generation of proinflammatory …

[PDF][PDF] Association between 1195G> A polymorphism of cyclooxygenase-2 gene with lung cancer risk: a meta-analysis

X Wang, T Wei, L Tian, M Wang, Y Qi, Q Shang - Int J Clin Exp Med, 2017 - e-century.us
The studies on the relationship between the 1195G> A polymorphism of cyclooxygenase-2
(COX-2) gene and the risk of lung cancer development have shown conflicting results. A …